GRAIL selects AWS as cloud provider
Amazon Web Services announced that GRAIL, a life sciences company whose mission is to detect cancer early, when it can be cured, has selected AWS as its cloud infrastructure provider. With more than a billion dollars in funding and advised by a world-class set of industry and cancer experts, GRAIL is combining high-intensity genomic sequencing with the techniques of modern data science as it seeks to transform the way cancer is diagnosed. GRAIL is running one of the largest clinical research programs ever pursued in genomic medicine, and AWS will enable GRAIL to ingest hundreds of thousands of records and genomic datasets, securely and reliably store them, and choose from a wide range of analytics and machine learning services to develop early detection products and demonstrate their clinical utility. GRAIL is collaborating with leading community and academic medical centers to conduct its studies, which will create unprecedented amounts of data as each patient record can contain as much as a terabyte. By migrating its core processing and analytical infrastructure from on-premises to AWS, GRAIL is leveraging AWS's unmatched breadth and depth of cloud functionality, HIPAA-compliant services, and proven security to build a data science pipeline that will allow GRAIL and its clinical partners to process and analyze large-scale datasets.